Tepadina - direct healthcare professional communication (DHPC)

thiotepa

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Tepadina (thiotepa) 100 mg: possible risk of defective vials in batches n°1709192/1, n°1709192/2 and n°1709192/3 presenting a crimp seal not properly fixed on the vial

Dissemination date: 01/06/2020

Key facts

• Medicine name:
  Tepadina
• Active substance:
  thiotepa
• Therapeutic area (MeSH):
  Hematopoietic Stem Cell Transplantation
• DHPC type:
  Quality defect
• Human ATC codes:
  L01AC01
• Dissemination date:
  01/06/2020